双侧突发性感音神经性听力损失的预后:系统评价与荟萃分析
本系统评价与荟萃分析纳入11项研究(368例双侧突发性感音神经性听力损失患者和2705例单侧患者),比较双侧与单侧突发性聋的特征及预后。结果显示双侧型占所有突发性聋的11.9%,激素治疗后纯音听阈改善较单侧型差15.3 dB,且双侧同时型与自身免疫病、心血管病和高血压的关联更强。
要点
- 双侧突发性感音神经性听力损失占所有突发性聋的11.9%(95%CI:6.4%-18.8%)。
- 激素治疗后纯音听阈改善双侧型较单侧型差15.3 dB(95%CI:14.6-15.9,p<0.0001)。
- 双侧同时型较单侧型更少为特发性病因(OR:0.4),更多与自身免疫病(OR:27.4)、心血管病(OR:2.3)和高血压(OR:2.5)相关。
核心结论
- 双侧突发性感音神经性听力损失是突发性聋中相当罕见的类型,与单侧型相比预后更差。
- 双侧突发性感音神经性听力损失、尤其是双侧同时型,与全身性疾病的相关性显著高于单侧型。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、Scopus和CINAHL数据库自建库至2023年12月5日的文献。
- 共纳入11项报告双侧突发性感音神经性听力损失及其同时型和序贯型患者特征与听力学结果的研究,包含368例双侧患者和2705例单侧患者。
- 对连续变量、比例(%)、均数差(Δ)和比值比(OR)进行荟萃分析。
主要发现
- 在所有突发性感音神经性听力损失病例中,合并患病率单侧型为88.1%(95%CI:81.2%-93.6%),双侧型为11.9%(95%CI:6.4%-18.8%)。
- 激素治疗后纯音听阈改善双侧型较单侧型差15.3 dB(95%CI:14.6-15.9,p<0.0001)。
- 双侧突发性感音神经性听力损失两个亚型之间治疗后纯音听阈改善无显著差异。
- 与单侧型相比,双侧同时型特发性病因的可能性显著更低(OR:0.4;95%CI:0.2-0.8;p=0.01)。
- 与单侧型相比,双侧同时型自身免疫病病因(OR:27.4;95%CI:2.2-336.1;p=0.01)、合并心血管病(OR:2.3;95%CI:1.1-5.1;p=0.03)和合并高血压(OR:2.5;95%CI:1.6-3.8;p<0.0001)的可能性显著更高。
关键数值与推荐
- 双侧突发性感音神经性听力损失占所有突发性感音神经性听力损失病例的11.9%(95%CI:6.4%-18.8%)。
- 激素治疗后纯音听阈改善双侧型较单侧型差15.3 dB(95%CI:14.6-15.9,p<0.0001)。
- 双侧同时型特发性病因OR为0.4(95%CI:0.2-0.8;p=0.01),自身免疫病病因OR为27.4(95%CI:2.2-336.1;p=0.01)。
- 双侧同时型合并心血管病OR为2.3(95%CI:1.1-5.1;p=0.03),合并高血压OR为2.5(95%CI:1.6-3.8;p<0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To comprehensively examine the characteristics and prognosis of bilateral sudden sensorineural hearing loss (BSSHL) and its subtypes compared to unilateral sudden sensorineural hearing loss (USSHL). DATA SOURCES: PubMed, Scopus, and CINAHL. REVIEW METHODS: Databases were searched from inception to December 5, 2023, for studies reporting patient characteristics and audiometric outcomes for BSSHL and its simultaneous (Si-BSSHL) and sequential (Se-BSSHL) subtypes. Meta-analysis of continuous measures, proportions (%), mean differences (Δ), and odds ratio (OR) were performed. RESULTS: Eleven studies were included, consisting of 368 patients with BSSHL and 2,705 patients with USSHL. The pooled prevalence among all SSHL cases was 88.1% (95% CI: 81.2%-93.6%) for USSHL and 11.9% (95% CI: 6.4% to 18.8%) for BSSHL. PTA improvement following treatment with steroids was significantly worse in patients with BSSHL (Δ15.3 dB; 95% CI: 14.6 to 15.9; p < 0.0001) compared to patients with USSHL. There was no significant difference in post-treatment PTA improvement between the BSSHL subtypes. Patients with Si-BSSHL were significantly less likely to have an idiopathic etiology (OR: 0.4; 95% CI: 0.2 to 0.8; p = 0.01) and significantly more likely to have an autoimmune disease etiology (OR: 27.4; 95% CI: 2.2 to 336.1; p = 0.01), comorbid cardiovascular disease (OR: 2.3; 95% CI: 1.1 to 5.1; p = 0.03), and comorbid hypertension (OR: 2.5; 95% CI: 1.6 to 3.8; p < 0.0001) compared to patients with USSHL. CONCLUSIONS: BSSHL is a considerably rarer form of SSHL with worse prognosis compared to USSHL. BSSHL, and Si-BSSHL in particular, has significantly greater associations with systemic pathologies compared to USSHL. Laryngoscope, 134:3883-3891, 2024.
引用
- Bhat AM, Nanu DP, Nguyen SA, et al. Prognosis of Bilateral Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-Analysis. Laryngoscope. 2024. PMID: 38506449. doi:10.1002/lary.31404
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。